Rikki L. Uhrich

A drug repurposing screen identifies hepatitis C antivirals as inhibitors of the SARS-CoV2 main protease

B. Kraemer, Jeremy D. Baker, J. Love, 2021, PloS one.

A drug repurposing screen identifies hepatitis C antivirals as inhibitors of the SARS-CoV-2 main protease

B. Kraemer, Jeremy D. Baker, J. Love, 2020 .

Targeting pathological tau by small molecule inhibition of the poly(A):MSUT2 RNA-protein interaction.

T. Strovas, B. Kraemer, Aleen Saxton, 2020, ACS chemical neuroscience.

Tau-RNA complexes inhibit microtubule polymerization and drive disease-relevant conformation change.

Caitlin S. Latimer, Nicole F. Liachko, B. Kraemer, 2023, Brain : a journal of neurology.

AlphaScreen Identifies MSUT2 Inhibitors for Tauopathy-Targeting Therapeutic Discovery

T. Strovas, B. Kraemer, Aleen Saxton, 2020, SLAS discovery : advancing life sciences R & D.